Drugs / Intramuscular influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02103023 Comparator | Mar → Nov 2014 | influenza | The University of Hong Kong | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intramuscular influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02103023 ↗ |
| Known as | Vaxigrip | “intramuscular trivalent influenza vaccine (Vaxigrip)” NCT02103023 ↗ |
| Modality | Vaccine | “intramuscular trivalent influenza vaccine (Vaxigrip)” NCT02103023 ↗ |
| Route | Intramuscular | “intramuscular trivalent influenza vaccine (Vaxigrip)” NCT02103023 ↗ |